Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/26/2010WO2010065825A3 Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer
08/26/2010WO2010062861A9 Bile acid recycling inhibitors for treatment of obesity and diabetes
08/26/2010WO2010062848A8 Substituted pyrazole compounds
08/26/2010WO2010062323A3 Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
08/26/2010WO2010060940A3 Hsp90 inhibitors for therapeutic treatment
08/26/2010WO2010059473A3 Compositions and methods for alleviating skin disorders
08/26/2010WO2010056048A3 Pharmaceutical composition for suppressing dna methyltransferase, containing aryloxyacetyl-based compounds as active ingredients
08/26/2010WO2010056041A3 Pharmaceutical composition for treating and preventing heart diseases caused by ischemia or ischemic reperfusion
08/26/2010WO2010054003A3 Methylindazole modulators of 5-ht3 receptors
08/26/2010WO2010053517A3 Combination therapy to combat helminth resistance
08/26/2010WO2010052575A3 Ngna compositions and methods of use
08/26/2010WO2010049678A3 Treatment of energy utilization diseases
08/26/2010WO2010047835A3 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
08/26/2010WO2010045377A3 Pyrimidine non-classical cannabinoid compounds and related methods of use
08/26/2010WO2010034758A3 dsRNA FOR TREATING VIRAL INFECTION
08/26/2010WO2010032880A3 Kinase inhibitory substances for cancer
08/26/2010WO2010032266A4 Novel single unit carbapenem aminoglycoside formulations
08/26/2010WO2010019772A3 Oxadiazole-2-oxides as antischistosomal agents
08/26/2010WO2010019701A3 Diaryl urea derivatives
08/26/2010WO2010015816A3 Treatment of lysosomal storage disorders and other proteostatic diseases
08/26/2010WO2010015815A3 Compounds for the treatment of flaviviral infections
08/26/2010WO2010004435A9 Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders
08/26/2010WO2009150547A3 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors
08/26/2010WO2009140469A3 Dosage regimen comprising ap02l/trail, anti-vegf / anti-cd20 and chemotherapy to treat nsclc or non-hodgkin's lymphoma, respectively
08/26/2010WO2009109501A3 Ocular pharmaceutical compositions
08/26/2010WO2009098448A8 Compounds
08/26/2010WO2009090085A8 Abnormal intraocular pressure treatment
08/26/2010WO2009089011A8 Resveratrol formulations
08/26/2010WO2009085314A8 Compositions and methods for treating diseases of the nail
08/26/2010WO2007039781A3 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors
08/26/2010US20100218266 Methods of identifying and using snail1 inhibitory compounds in chondrodysplasia treatment and preparation of pharmaceutical compositions
08/26/2010US20100218265 Immune system mediator
08/26/2010US20100217727 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications
08/26/2010US20100217379 Implantable medical device comprising a pro-healing poly(ester-amide)
08/26/2010US20100217287 Self-assembling fibrous networks
08/26/2010US20100217045 Composition to enhance the bioavailability of curcumin
08/26/2010US20100217028 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
08/26/2010US20100217025 Ferric organic compounds, uses thereof and methods of making same
08/26/2010US20100216987 Synthesis of naturally occuring ecteinascidins and related compounds
08/26/2010US20100216893 Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
08/26/2010US20100216891 Aromatic antihypertensive agent, and method for lowering blood pressure in mammals
08/26/2010US20100216890 Disinfectant
08/26/2010US20100216888 Liquid compositions containing solubilized benzoyl peroxide, means for applying same and methods of treatment using same
08/26/2010US20100216887 Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
08/26/2010US20100216886 Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
08/26/2010US20100216885 Orodispersible composition comprising polyunsaturated fatty acids without bad odor or taste
08/26/2010US20100216884 Nitrated-fatty acids modulation of type ii diabetes
08/26/2010US20100216883 Method of using abscisic acid to treat and prevent diseases and disorders
08/26/2010US20100216882 Aspirin-triggered lipid mediators
08/26/2010US20100216881 Enhydrazone esters for treating asthma, allergy and inflammation
08/26/2010US20100216880 Transdermal compositions for anticholinergic agents
08/26/2010US20100216878 Amino Acid Derivatives
08/26/2010US20100216877 Storage Stable Prostaglandin Product
08/26/2010US20100216876 Antidiarrhetic composition, product containing the same and method of preventing diahhrea
08/26/2010US20100216875 Methods of treating alzheimer's disease
08/26/2010US20100216874 Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
08/26/2010US20100216872 Plant extract from low-thc cannabis for the treatment of disease
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216870 Novel Genes Encoding a Nystatin Polyketide Synthase and Their Manipulation and Utility
08/26/2010US20100216869 Artemisinin derivatives for the treatment of melanoma
08/26/2010US20100216868 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
08/26/2010US20100216867 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
08/26/2010US20100216866 RNAi Modulation of APOB and Uses Thereof
08/26/2010US20100216865 MicroRNA COMPOSITIONS IN THE TREATMENT OF VEGF-MEDIATED DISORDERS
08/26/2010US20100216864 RNA Antagonist Compounds for the Modulation of PCSK9
08/26/2010US20100216863 Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
08/26/2010US20100216862 Pyrrole Derivatives As Therapeutic Compounds
08/26/2010US20100216861 Amino arylsulfonamide compounds and their use as 5-ht6 ligands
08/26/2010US20100216860 Novel compounds
08/26/2010US20100216859 Curcumin analog compositions and related methods
08/26/2010US20100216858 Bendamustine cyclopolysaccharide compositions
08/26/2010US20100216857 Method of treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/26/2010US20100216856 Protective agent for retinal nerve or optic nerve
08/26/2010US20100216855 Imidazaolone derivatives,preparation thereof and biological use of same
08/26/2010US20100216854 1,3 and 1,3,5 substituted imidazoles as antihypertensives
08/26/2010US20100216853 Methods and Compositions for Modulating P300/CBP Activity
08/26/2010US20100216852 Methods for screening antimicrobial and antiviral compounds and uses thereof
08/26/2010US20100216851 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
08/26/2010US20100216848 Liquid pharmaceutical compositions for parenteral administration of a substituted amide
08/26/2010US20100216847 Nornicotine for the treatment of pain
08/26/2010US20100216846 Trisubstituted 1,2,4 triazoles
08/26/2010US20100216845 Isoxazoles / o-pyridines with ethyl and ethenyl linker
08/26/2010US20100216844 Carboxamide compounds and their use as calpain inhibitors
08/26/2010US20100216843 Novel salt 628
08/26/2010US20100216842 Narcotic Emulsion Formulations for Treatment of Cancer Pain
08/26/2010US20100216841 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216839 Pim kinase inhibitors and methods of their use
08/26/2010US20100216838 Fexofenadine base polymorphic forms
08/26/2010US20100216837 Glycine transport inhibitors
08/26/2010US20100216836 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
08/26/2010US20100216835 Method For Modulating Microbial Quorum Sensing
08/26/2010US20100216834 Hiv integrase inhibitors
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216832 Method for Assaying FTO (2-Oxoglutarate Dependent Oxygenase) Activity
08/26/2010US20100216831 Desloratadine crystalline forms mixtures having a low level of residual solvents
08/26/2010US20100216830 Oral Composition Comprising A Cooling Agent
08/26/2010US20100216829 Method and compositions for deterring abuse of opioid containing dosage forms
08/26/2010US20100216828 Methods and compositions for treating cancers
08/26/2010US20100216827 Aryl gpr120 receptor agonists and uses thereof
1 ... 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 ... 7860